A new approach to viral chemotherapy. Inhibitors of glycoprotein synthesis

Refractive error consequences of reversed-optic AMO SI-40NB intraocular lens.

Ophthalmology·1999

Inhibition of vaccinia virus replication by N-(phosphonoacetyl)-L-aspartate: differential effects on viral gene expression result from a reduced pyrimidine nucleotide pool.

Virology·1997

Evaluation of the antiviral activity of N-(phosphonoacetyl)-L-aspartate against paramyxoviruses in tissue culture and against respiratory syncytial virus in cotton rats.

Antiviral research·1995

The incidence of atonic pupil following cataract surgery.

Archives of ophthalmology (Chicago, Ill. : 1960)·1995

Corneal topographic changes induced by pterygia.

Journal of refractive surgery (Thorofare, N.J. : 1995)·1995

Introduction: are aging and space effects similar?

Experimental gerontology·1991

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Molecular Insights into Covalent Binding between Anthocyanin C3G and α-Glucosidase: Interaction of Flavylium with Cysteine Thiol.

Journal of agricultural and food chemistry·2026

pH-Responsive Dopamine-Grafted Polysaccharide Hydrogel with Enhanced Antibacterial and Hemostatic Properties.

ACS applied bio materials·2026

Antibody peptide conjugates as multifunctional therapeutics: Mechanisms, challenges, and prospects.

Acta pharmaceutica Sinica. B·2026

Ginsenoside Compound K activates EGFR to enhance the skin barrier- and moisturization-related molecules.

Journal of ginseng research·2026

Enzymatic synthesis of geranic acid and its protective effects against UVB-induced skin photodamage.

Frontiers in bioengineering and biotechnology·2026

Synthesis of 2,3-dideoxy-C-3-thiopyrimidine based new Glycohybrids.

Carbohydrate research·2026

Related Experiment Videos

A new approach to viral chemotherapy. Inhibitors of glycoprotein synthesis

Related Concept Videos

Refractive error consequences of reversed-optic AMO SI-40NB intraocular lens.

Inhibition of vaccinia virus replication by N-(phosphonoacetyl)-L-aspartate: differential effects on viral gene expression result from a reduced pyrimidine nucleotide pool.

Evaluation of the antiviral activity of N-(phosphonoacetyl)-L-aspartate against paramyxoviruses in tissue culture and against respiratory syncytial virus in cotton rats.

The incidence of atonic pupil following cataract surgery.

Corneal topographic changes induced by pterygia.

Introduction: are aging and space effects similar?

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Molecular Insights into Covalent Binding between Anthocyanin C3G and α-Glucosidase: Interaction of Flavylium with Cysteine Thiol.

pH-Responsive Dopamine-Grafted Polysaccharide Hydrogel with Enhanced Antibacterial and Hemostatic Properties.

Antibody peptide conjugates as multifunctional therapeutics: Mechanisms, challenges, and prospects.

Ginsenoside Compound K activates EGFR to enhance the skin barrier- and moisturization-related molecules.

Enzymatic synthesis of geranic acid and its protective effects against UVB-induced skin photodamage.

Synthesis of 2,3-dideoxy-C-3-thiopyrimidine based new Glycohybrids.

Related Experiment Videos

A new approach to viral chemotherapy. Inhibitors of glycoprotein synthesis

Related Concept Videos

Related Articles